Digital Health: Access to Care and the Generational Divide

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

Starting Sept. 25, Americans can again order free COVID-19 tests through the federal government.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

The five most recent states to expand the scope of reimbursement for pharmacists are Maryland, Missouri, North Dakota, Virginia and Wyoming